Cargando…

Immunotherapy for Esophageal Cancer: State-of-the Art in 2021

SIMPLE SUMMARY: The aim of this review was to describe the rationale for immunotherapy in different stages of esophageal cancer (EC) treatment, with a particular accent on curative intent treatment of locally advanced disease for the two predominant histological types (adenocarcinoma and squamous ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teixeira Farinha, Hugo, Digklia, Antonia, Schizas, Dimitrios, Demartines, Nicolas, Schäfer, Markus, Mantziari, Styliani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833794/ https://www.ncbi.nlm.nih.gov/pubmed/35158822 http://dx.doi.org/10.3390/cancers14030554

Ejemplares similares

Esophageal Cancer in Elderly Patients, Current Treatment Options and Outcomes; A Systematic Review and Pooled Analysis
por: Mantziari, Styliani, et al.
Publicado: (2021)

A Comprehensive Review of Prognostic Factors in Patients with Gastric Adenocarcinoma
por: Mantziari, Styliani, et al.
Publicado: (2023)

Neoadjuvant Chemoradiotherapy versus Chemotherapy for Gastroesophageal Junction Adenocarcinoma; Which Is the Optimal Treatment Option?
por: Zandirad, Eric, et al.
Publicado: (2022)

Early postoperative outcomes of staging laparoscopy for peritoneal metastases with or without pressurized intra-peritoneal aerosol chemotherapy (PIPAC)
por: Teixeira Farinha, Hugo, et al.
Publicado: (2022)

(18)F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer
por: Mantziari, Styliani, et al.
Publicado: (2020)

Postoperative Albumin Drop Is a Marker for Surgical Stress and a Predictor for Clinical Outcome: A Pilot Study
por: Hübner, Martin, et al.
Publicado: (2016)

Is postoperative decrease of serum albumin an early predictor of complications after major abdominal surgery? A prospective cohort study in a European centre
por: Labgaa, Ismail, et al.
Publicado: (2017)

Cost-Benefit Analysis of an Enhanced Recovery Program for Gastrectomy A Retrospective Controlled Analysis
por: Luzuy-Guarnero, Valentine, et al.
Publicado: (2021)

The “Real R0”: A Resection Margin Smaller Than 0.1 cm is Associated with a Poor Prognosis After Oncologic Esophagectomy
por: St-Amour, Penelope, et al.
Publicado: (2021)

Preserving Surgical Professionalism in Social Media; Long Live the Media, But Let Live the Surgeon
por: Mantziari, Styliani, et al.
Publicado: (2021)

Inflammatory Myofibroblastic Tumour: State of the Art
por: Gros, Louis, et al.
Publicado: (2022)

Management of a Late-Term Hiatal Hernia with Intrathoracic Pouch Migration After Roux-en-Y Gastric Bypass
por: Thomopoulos, Theodoros, et al.
Publicado: (2022)

Gastro-Intestinal Disorders and Micronutrient Deficiencies following Oncologic Esophagectomy and Gastrectomy
por: Teixeira Farinha, Hugo, et al.
Publicado: (2023)

Immunotherapy for Hepatocellular Carcinoma: A 2021 Update
por: Kole, Christo, et al.
Publicado: (2020)

ASO Author Reflections: R0 Resection After Oncologic Esophagectomy—Cutting on the Edge (0 cm) is Not Enough
por: St-Amour, Penelope, et al.
Publicado: (2021)

Emergency right colectomy: which strategy when primary anastomosis is not feasible?
por: Teixeira Farinha, Hugo, et al.
Publicado: (2016)

Long-term weight loss and metabolic benefit from Roux-en-Y gastric bypass in patients with superobesity
por: Mantziari, Styliani, et al.
Publicado: (2022)

Immunotherapy for Esophageal Cancers: What Is Practice Changing in 2021?
por: Puhr, Hannah Christina, et al.
Publicado: (2021)

Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy
por: Teixeira Farinha, Hugo, et al.
Publicado: (2018)

Proposition of a simple binary grading of estimated blood loss during colon surgery
por: Teixeira Farinha, Hugo, et al.
Publicado: (2021)

Imaging of tumour response to immunotherapy
por: Dromain, Clarisse, et al.
Publicado: (2020)

Histological regression of peritoneal metastases of recurrent tubo-ovarian cancer after systemic chemotherapy
por: Pache, Basile, et al.
Publicado: (2022)

Histological regression of gastrointestinal peritoneal metastases after systemic chemotherapy
por: Toussaint, Laura, et al.
Publicado: (2021)

Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach
por: Nikolaou, Michail, et al.
Publicado: (2019)

Magnesium for Pain Treatment in 2021? State of the Art
por: Morel, Véronique, et al.
Publicado: (2021)

Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study
por: Hübner, Martin, et al.
Publicado: (2017)

Impact of positive microscopic resection margins (R1) after gastrectomy in diffuse-type gastric cancer
por: Gaspar-Figueiredo, Sérgio, et al.
Publicado: (2023)

Valproic Acid and Breast Cancer: State of the Art in 2021
por: Wawruszak, Anna, et al.
Publicado: (2021)

Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study
por: Teixeira Farinha, Hugo, et al.
Publicado: (2017)

Eosinophilic Esophagitis and Microbiota: State of the Art
por: Mennini, Maurizio, et al.
Publicado: (2021)

Recombinant allergens for immunotherapy: state of the art
por: Zhernov, Yury, et al.
Publicado: (2019)

Comparison of integrin α(v)β(3) expression with (68)Ga-NODAGA-RGD PET/CT and glucose metabolism with (18)F-FDG PET/CT in esophageal or gastroesophageal junction cancers
por: Dietz, Matthieu, et al.
Publicado: (2023)

First communication on the efficacy of combined (177)Lutetium-PSMA with immunotherapy outside prostate cancer
por: Digklia, Antonia, et al.
Publicado: (2022)

Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives
por: Maselli, Felicia Maria, et al.
Publicado: (2023)

Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment
por: Schizas, Dimitrios, et al.
Publicado: (2018)

Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights
por: Kole, Christo, et al.
Publicado: (2022)

Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer
por: Digklia, Antonia, et al.
Publicado: (2014)

Synchronous resection of esophageal cancer and other organ malignancies: A systematic review
por: Papaconstantinou, Dimitrios, et al.
Publicado: (2019)

The Landscape and Therapeutic Targeting of BRCA1, BRCA2 and Other DNA Damage Response Genes in Pancreatic Cancer
por: Voutsadakis, Ioannis A., et al.
Publicado: (2023)

Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
por: Kang, Jin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tr34375v45na4vrif54vsvacgr